Table 1 Baseline characteristics of enrolled patients with pathologically proved prostate cancer
From: In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied?
Clinicopathologic findings | Patients (n = 80) |
|---|---|
Age (years; mean, range) | 70.7 (59–83) |
Serum PSA | |
Total PSA | 13.09 (1.3–66.2) |
Free PSA | 1.70 (0.2–7.2) |
Cancer location | |
Transition zone | 22 |
Peripheral zone | 44 |
Transition and peripheral zone | 14 |
Pathologic T stage | |
T2a, T2b | 16 |
T2c | 41 |
T3a | 13 |
T3b | 10 |
Pathologic N stage | |
N0 | 76 |
N1 | 4 |
Seminal vesicle invasion | |
No | 71 |
Yes | 9 |
Extracapsular extension | |
No | 49 |
Yes | 31 |
Gleason score (GS) | |
6 | 6 |
7 | 63 |
8-9 | 11 |